308 related articles for article (PubMed ID: 7993124)
1. [A clinical study of sixteen polycythemia vera cases--acute myeloblastic leukemia in patients with polycythemia vera].
Takeyama H; Shimokawa T; Yamada H; Watanabe E
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2833-7. PubMed ID: 7993124
[TBL] [Abstract][Full Text] [Related]
2. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature.
Swolin B; Rödjer S; Westin J
Ann Hematol; 2008 Jun; 87(6):467-74. PubMed ID: 18351338
[TBL] [Abstract][Full Text] [Related]
3. [Polycythemia vera as a multiphasic clonal panmyelopathy: diagnostic profile, chronic pathological progression and effect of therapy on the survival of 74 cases].
Sánchez Fayos J; Prieto E; Román A; Soto de Ozaeta C; Nevado I; Richart A; Chica E; Loscertales J; Calabuig T; Benítez J; Outeiriño J
Sangre (Barc); 1996 Dec; 41(6):447-57. PubMed ID: 9148422
[TBL] [Abstract][Full Text] [Related]
4. Megakaryoblastic transformation of polycythemia vera with hypercalcemia.
Kurosawa M; Iwasaki H
Ann Hematol; 2002 Nov; 81(11):668-71. PubMed ID: 12454709
[TBL] [Abstract][Full Text] [Related]
5. [Polycythemia vera progressing to acute lymphoblastic leukemia after 13 years].
Arai Y; Masuda M; Okamura T; Wada M; Motoji T; Mizoguchi H
Rinsho Ketsueki; 1996 Dec; 37(12):1405-9. PubMed ID: 8997130
[TBL] [Abstract][Full Text] [Related]
6. Course and transformation of polycythaemia vera in relation to therapy.
Burger T; Schmelczer M; Molnár L; Pajor L; Koszorus S
Acta Med Hung; 1988; 45(1):97-113. PubMed ID: 3412864
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of pipobroman in the treatment of polycythemia vera: long-term results in 163 patients.
Passamonti F; Brusamolino E; Lazzarino M; Baraté C; Klersy C; Orlandi E; Canevari A; Castelli G; Merante S; Bernasconi C
Haematologica; 2000 Oct; 85(10):1011-8. PubMed ID: 11025590
[TBL] [Abstract][Full Text] [Related]
8. [Polycythemia vera: clinical aspects and course in 86 patients].
Egli F; Wieczorek A; Niemöller M; Rhyner K
Schweiz Med Wochenschr; 1988 Dec; 118(52):1969-75. PubMed ID: 3217777
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic effect of ranimustine (MCNU) on essential thrombocythemia and polycythemia vera].
Nagai M; Tasaka T; Kamano H; Ohnishi H; Taoka T; Ikeda K; Kubota Y; Tanaka T; Irino S
Gan To Kagaku Ryoho; 1988 Dec; 15(12):3267-70. PubMed ID: 3196045
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloblastic leukemia with polycythemia vera. Treated with busulfan and phlebotomy.
Dittmar K
N Y State J Med; 1979 Apr; 79(5):758-61. PubMed ID: 286175
[No Abstract] [Full Text] [Related]
11. IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience.
Yavuz S; Paydas S; Disel U; Sahin B
Am J Ther; 2006; 13(5):389-93. PubMed ID: 16988532
[TBL] [Abstract][Full Text] [Related]
12. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
Cortes J; Giles F; O'Brien S; Thomas D; Albitar M; Rios MB; Talpaz M; Garcia-Manero G; Faderl S; Letvak L; Salvado A; Kantarjian H
Cancer; 2003 Jun; 97(11):2760-6. PubMed ID: 12767088
[TBL] [Abstract][Full Text] [Related]
13. Leukemic transformation of polycythemia vera after treatment with hydroxyurea with abnormalities of chromosome 17.
Tóthová E; Fricová M; Stecová N; Hlebasková M; Kafková A; Raffac S; Guman T; Svorcová E; Nebesnáková E
Neoplasma; 2001; 48(5):389-92. PubMed ID: 11845984
[TBL] [Abstract][Full Text] [Related]
14. [The risk factors for thrombosis, myelofibrosis and leukemia transformation in patients with polycythemia vera].
Bai J; Xue YP; Ye L; Yao JF; Zhou CL; Qian LS; Yang RC; Li HY; Zhang HY; Shao ZH
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):685-8. PubMed ID: 18399175
[TBL] [Abstract][Full Text] [Related]
15. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Nand S; Stock W; Godwin J; Fisher SG
Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
[TBL] [Abstract][Full Text] [Related]
16. Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia.
Passamonti F; Malabarba L; Orlandi E; Baratè C; Canevari A; Brusamolino E; Bonfichi M; Arcaini L; Caberlon S; Pascutto C; Lazzarino M
Haematologica; 2003 Jan; 88(1):13-8. PubMed ID: 12551821
[TBL] [Abstract][Full Text] [Related]
17. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
18. Leukemic transformation in three patients with polycythemia vera. Analysis of the clinicopathological features and N-ras gene mutation.
Sakai H; Karasawa M; Okamoto K; Maehara T; Tsukamoto N; Murakami H; Naruse T; Morita K; Tsuchiya J
J Med; 1996; 27(3-4):183-91. PubMed ID: 8982966
[TBL] [Abstract][Full Text] [Related]
19. A single-center, retrospective study of management and outcome of 45 elderly AML patients, diagnosed in 2001.
Alymara V; Tzouvara E; Vartholomatos G; Chaidos A; Tsiara S; Bourantas KL
J Exp Clin Cancer Res; 2004 Sep; 23(3):447-54. PubMed ID: 15595635
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
